Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Fas lpr Mice.

Lee HK, Kim EY, Kim HS, Park EJ, Lee HJ, Lee TY, Kim KS, Bae SC, Hong JT, Kim Y, Han SB.

Stem Cells Int. 2020 Mar 5;2020:5617192. doi: 10.1155/2020/5617192. eCollection 2020.

2.

Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages.

Park KR, Hwang CJ, Yun HM, Yeo IJ, Choi DY, Park PH, Kim HS, Lee JT, Jung YS, Han SB, Hong JT.

Stem Cell Res Ther. 2020 Mar 4;11(1):63. doi: 10.1186/s13287-020-01590-1.

3.

Pilot Study of Aerosolised Plus Intravenous Vancomycin in Mechanically Ventilated Patients with Methicillin-Resistant Staphylococcus Aureus Pneumonia.

Cho JY, Kim HS, Yang HJ, Lee YJ, Park JS, Yoon HI, Kim HB, Yim JJ, Lee JH, Lee CT, Cho YJ.

J Clin Med. 2020 Feb 9;9(2). pii: E476. doi: 10.3390/jcm9020476.

4.

Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study.

Kim Y, Kim HS, Park JS, Cho YJ, Yoon HI, Lee SM, Lee JH, Lee CT, Lee YJ.

J Clin Med. 2019 Dec 27;9(1). pii: E69. doi: 10.3390/jcm9010069.

5.

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy.

Kim HS, Lee JS, Lee HK, Park EJ, Jeon HW, Kang YJ, Lee TY, Kim KS, Bae SC, Park JH, Han SB.

Immune Netw. 2019 Oct 14;19(5):e36. doi: 10.4110/in.2019.19.e36. eCollection 2019 Oct.

6.

Redundant combinations of antianaerobic antimicrobials: impact of pharmacist-based prospective audit and feedback and prescription characteristics.

Kim M, Kim HS, Song YJ, Lee E, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB.

Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):75-83. doi: 10.1007/s10096-019-03687-9. Epub 2019 Sep 3.

PMID:
31482420
7.

Characterization of morphological changes of B16 melanoma cells under natural killer cell attack.

Kim JS, Kim B, Lee HK, Kim HS, Park EJ, Choi YJ, Ahn GB, Yun J, Hong JT, Kim Y, Han SB.

Int Immunopharmacol. 2019 Feb;67:366-371. doi: 10.1016/j.intimp.2018.12.037. Epub 2018 Dec 21.

PMID:
30583235
8.

Kidney transplantation using expanded criteria deceased donors with terminal acute kidney injury: a single center experience in Korea.

Ko KJ, Kim YH, Kim MH, Jun KW, Kwon KH, Kim HS, Kim SD, Park SC, Kim JI, Yun SS, Moon IS, Hwang JK.

Ann Surg Treat Res. 2018 Nov;95(5):278-285. doi: 10.4174/astr.2018.95.5.278. Epub 2018 Oct 25.

9.

Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study.

Kim HS, Lee E, Cho YJ, Lee YJ, Rhie SJ.

J Clin Pharm Ther. 2019 Feb;44(1):84-90. doi: 10.1111/jcpt.12762. Epub 2018 Sep 22.

PMID:
30243033
10.

CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells.

Kim J, Kim JS, Lee HK, Kim HS, Park EJ, Choi JE, Choi YJ, Shin BR, Kim EY, Hong JT, Kim Y, Han SB.

Int Immunopharmacol. 2018 Oct;63:66-73. doi: 10.1016/j.intimp.2018.07.026. Epub 2018 Jul 31.

PMID:
30075430
11.

Effect of a Combination of Prednisone or Mycophenolate Mofetil and Mesenchymal Stem Cells on Lupus Symptoms in MRL.Faslpr Mice.

Lee HK, Kim KH, Kim HS, Kim JS, Lee JH, Ji A, Kim KS, Lee TY, Chang IY, Bae SC, Hong JT, Kim Y, Han SB.

Stem Cells Int. 2018 Jul 3;2018:4273107. doi: 10.1155/2018/4273107. eCollection 2018.

12.

Impact of Intervention by an Antimicrobial Stewardship Team on Conversion from Intravenous to Oral Fluoroquinolones.

Park SM, Kim HS, Jeong YM, Lee JH, Lee E, Lee E, Song KH, Kim HB, Kim ES.

Infect Chemother. 2017 Mar;49(1):31-37. doi: 10.3947/ic.2017.49.1.31. Epub 2017 Mar 13.

13.

Feasibility and Efficacy of Intra-Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy.

Na Kim H, Yeol Kim D, Hee Oh S, Sook Kim H, Suk Kim K, Hyu Lee P.

Stem Cells Transl Med. 2017 May;6(5):1424-1433. doi: 10.1002/sctm.16-0438. Epub 2017 Mar 13.

14.

CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms.

Lee HK, Kim HS, Kim JS, Kim YG, Park KH, Lee JH, Kim KH, Chang IY, Bae SC, Kim Y, Hong JT, Kehrl JH, Han SB.

Sci Rep. 2017 Jan 24;7:41258. doi: 10.1038/srep41258.

15.

Curdlan activates dendritic cells through dectin-1 and toll-like receptor 4 signaling.

Kim HS, Park KH, Lee HK, Kim JS, Kim YG, Lee JH, Kim KH, Yun J, Hwang BY, Hong JT, Kim Y, Han SB.

Int Immunopharmacol. 2016 Oct;39:71-78. doi: 10.1016/j.intimp.2016.07.013. Epub 2016 Jul 21.

PMID:
27449326
16.

A mechanistic study of in situ chemical cleaning-in-place for a PTFE flat sheet membrane: fouling mitigation and membrane characterization.

Lee EJ, An AK, Hadi P, Yan DY, Kim HS.

Biofouling. 2016;32(3):301-12. doi: 10.1080/08927014.2016.1140746.

PMID:
26905269
17.

Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.

Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD.

Int J Antimicrob Agents. 2015 Dec;46(6):689-95. doi: 10.1016/j.ijantimicag.2015.09.010. Epub 2015 Oct 17.

PMID:
26555059
18.

Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models.

Kim HS, Ryu HS, Kim JS, Kim YG, Lee HK, Jung JK, Kwak YS, Lee K, Seo SY, Yun J, Kang JS, Hong JT, Kim Y, Han SB.

Arch Pharm Res. 2015;38(5):813-25. doi: 10.1007/s12272-014-0456-8. Epub 2014 Jul 31.

PMID:
25074039
20.

Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.

Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD.

Int J Antimicrob Agents. 2014 Feb;43(2):179-83. doi: 10.1016/j.ijantimicag.2013.10.017. Epub 2013 Nov 18.

PMID:
24315788

Supplemental Content

Loading ...
Support Center